Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2414]

SABCS 2013: Presurgery treatment combination more effective for women with triple-negative breast cancer

SABCS 2013: Presurgery treatment combination more effective for women with triple-negative breast cancer

SABCS 2013: Bisphosphonate treatment fails to improve outcomes for women with chemoresistant breast cancer

SABCS 2013: Bisphosphonate treatment fails to improve outcomes for women with chemoresistant breast cancer

SABCS 2013: Study identifies highly effective treatment option for patients with HER2- positive breast cancer

SABCS 2013: Study identifies highly effective treatment option for patients with HER2- positive breast cancer

ASH 2013: Final stage II results of the CLL11 trial

ASH 2013: Final stage II results of the CLL11 trial

ASH 2013: Bcl-2 inhibitor ABT-199 monotherapy shows anti-tumour activity in high-risk chronic lymphocytic leukaemia and small lymphocytic lymphoma

ASH 2013: Bcl-2 inhibitor ABT-199 monotherapy shows anti-tumour activity in high-risk chronic lymphocytic...

FDA approves new drug for advanced prostate cancer

FDA approves new drug for advanced prostate cancer

Untreated cancer pain a ‘scandal of global proportions,’ survey shows

Untreated cancer pain a ‘scandal of global proportions,’ survey shows

Insight into melanoma drug resistance pathways identifies potential new treatment option

Insight into melanoma drug resistance pathways identifies potential new treatment option

Studies identify cell-signaling pathway alterations responsible for melanoma drug resistance

Studies identify cell-signaling pathway alterations responsible for melanoma drug resistance

Study finds new explanation for resistance to breast cancer treatment

Study finds new explanation for resistance to breast cancer treatment

More from ecancer